SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K
                                 CURRENT REPORT
                     PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

         Date of Report (Date of earliest event reported): May 29, 2003

                            DRAGON PHARMACEUTICAL INC
               (Exact Name of Registrant as Specified in Charter)


      Florida                       0-27937                     65-0142474
  (State or Other                 (Commission                 (IRS Employer
  Jurisdiction of                 File Number)              Identification No.)
   Incorporation)


       1055 Hastings Street, Suite 1900                 V6E 2E9
          Vancouver, British Columbia                  (Zip Code)
  (Address of Principal Executive Offices)


       Registrant's telephone number, including area code: (604) 669-8817

                                       N/A
          (Former Name or Former Address, if Changed Since Last Report)


<PAGE>


Item 7. Financial Statements and Exhibits

     (c)  Exhibits

          99.1 Press release dated May 29, 2003.

Item 9. Other  Regulation  FD  Disclosure/Results  of  Operations  and Financial
     Condition (Item 12)

     The purpose of this current  report on Form 8-K is to disclose  that Dragon
Pharmaceutical  Inc.  issued a press  release  on May 29,  2003  announcing  and
summarizing its unaudited  financial  results for the three-month  period ending
March 31, 2003.  The press release under this Item 9 is being  furnished to meet
the requirements of Item 12 of Form 8-K.


                                             SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                             DRAGON PHARMACEUTICAL INC.

Date: May 29, 2003                  By:      /s/Matthew Kavanagh
                                             ___________________________________
                                    Name:             Matthew Kavanagh
                                    Title:    Director of Finance and Compliance
                                             (Principal Financial and Accounting
                                                          Officer)
[{"type": "8-K", "sequence": "1", "filename": "form8kfor052903.txt", "secsgml_size_bytes": 2484}]
{"company-data": {"conformed-name": "DRAGON PHARMACEUTICALS INC", "cik": "0001075206", "assigned-sic": "2834", "irs-number": "650142474", "state-of-incorporation": "FL", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-27937", "film-number": "03724291"}, "business-address": {"street1": "543 GRANVILLE STREET SUITE 1200", "city": "VANCOUVER BC V6C 1X8", "state": "A1"}, "mail-address": {"street1": "543 GRANVILLE STREET SUITE 1200", "street2": "VANCOUVER BRITISH COLUMBIA CANADA V6C1X", "city": "VANCOUVER BRITISH CO"}}
SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K
                                 CURRENT REPORT
                     PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

         Date of Report (Date of earliest event reported): May 29, 2003

                            DRAGON PHARMACEUTICAL INC
               (Exact Name of Registrant as Specified in Charter)

      Florida                       0-27937                     65-0142474
  (State or Other                 (Commission                 (IRS Employer
  Jurisdiction of                 File Number)              Identification No.)
   Incorporation)

       1055 Hastings Street, Suite 1900                 V6E 2E9
          Vancouver, British Columbia                  (Zip Code)
  (Address of Principal Executive Offices)

       Registrant's telephone number, including area code: (604) 669-8817

                                       N/A
          (Former Name or Former Address, if Changed Since Last Report)
Item 7. Financial Statements and Exhibits

     (c)  Exhibits

          99.1 Press release dated May 29, 2003.

Item 9. Other  Regulation  FD  Disclosure/Results  of  Operations  and Financial
     Condition (Item 12)

     The purpose of this current  report on Form 8-K is to disclose  that Dragon
Pharmaceutical  Inc.  issued a press  release  on May 29,  2003  announcing  and
summarizing its unaudited  financial  results for the three-month  period ending
March 31, 2003.  The press release under this Item 9 is being  furnished to meet
the requirements of Item 12 of Form 8-K.

                                             SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                             DRAGON PHARMACEUTICAL INC.

Date: May 29, 2003                  By:      /s/Matthew Kavanagh
                                             ___________________________________
                                    Name:             Matthew Kavanagh
                                    Title:    Director of Finance and Compliance
                                             (Principal Financial and Accounting
                                                          Officer)